Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway

Background: Renal tubulointerstitial fibrosis is the key pathological feature in chronic kidney diseases (CKDs) with no satisfactory therapies in clinic. Cilomilast is a second-generation, selective phosphodiesterase-4 inhibitor, but its role in renal tubulointerstitial fibrosis in CKD remains uncle...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Man, Li, Shumin, Wang, Jiajia, Huang, Songming, Zhang, Aihua, Zhang, Yue, Gu, Wei, Yu, Xiaowen, Jia, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859332/
https://www.ncbi.nlm.nih.gov/pubmed/33553218
http://dx.doi.org/10.3389/fmed.2020.626140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859332/
https://www.ncbi.nlm.nih.gov/pubmed/33553218
http://dx.doi.org/10.3389/fmed.2020.626140

Ejemplares similares